Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells

被引:0
|
作者
Zhenguang Chen
Tao Wang
Lie Cai
Chunhua Su
Beilong Zhong
Yiyan Lei
Andy Peng Xiang
机构
[1] Sun Yat-sen University,Department of Thoracic Surgery, The First Affiliated Hospital
[2] Lung Cancer Research Center of Sun Yat-sen University,Center for Stem Cell Biology and Tissue Engineering
[3] Sun Yat-sen University,Department of Rehabilitation, The First Affiliated Hospital
[4] Key Laboratory for Stem Cells and Tissue Engineering,Department of Thoracic Surgery, The Fifth Affiliated Hospital
[5] Ministry of Education,undefined
[6] Sun Yat-sen University,undefined
[7] Sun Yat-sen University,undefined
关键词
Oct-4; Non-small cell lung cancer; Prognosis; Proliferation; Angiogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Clinical applications of circulating tumor cells in non-small cell lung cancer
    Gupta, Varun
    Noh, Ka-Won
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 135 - 135
  • [42] Biclonal Non-small Cell Lung Cancer in Disseminated Tumor Cells and Tissue
    Puggina, Anna
    Kuemmerlen, Verena
    Joehrens-Leder, Korinna
    Keilholz, Ulrich
    Fusi, Alberto
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1202 - 1203
  • [43] Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer
    Kikuchi, Junko
    Kinoshita, Ichiro
    Shimizu, Yasushi
    Kikuchi, Eiki
    Takeda, Kayoko
    Aburatani, Hiroyuki
    Oizumi, Satoshi
    Konishi, Jun
    Kaga, Kichizo
    Matsuno, Yoshihiro
    Birrer, Michael J.
    Nishimura, Masaharu
    Dosaka-Akita, Hirotoshi
    LUNG CANCER, 2011, 72 (02) : 229 - 237
  • [44] Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
    Li, Zhiqiang
    Huang, Yunfei
    Zhou, Rongsheng
    Li, Zhicheng
    Yan, Qitao
    MEDICINE, 2023, 102 (29) : E34312
  • [45] Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer
    Li, Bin
    Yao, Zhouhong
    Wan, Yunyan
    Lin, Dianjie
    ONCOTARGET, 2016, 7 (47) : 77342 - 77347
  • [46] The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer
    Enwere, Emeka K.
    Dean, Michelle L.
    Li, Haocheng
    D'Silva, Adrijana
    Bebb, D. Gwyn
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 496 - +
  • [47] MYELOPEROXIDASE IMPACTS LUNG CANCER CELLS AND DRIVES TUMOR PROGRESSION IN NON-SMALL CELL LUNG CANCER
    Mujkanovic, Nejra Cosic
    Valadez-Cosmes, Paulina
    Maitz, Kathrin
    Lueger, Anna
    Kindler, Oliver
    Marsche, Gunther
    Kargl, Julia
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 201 : 53 - 53
  • [48] CLINICAL AND PATHOLOGICAL ANALYSES OF ISOLATED TUMOR CELLS IN NON SMALL CELL LUNG CANCER -CLINICOPATHOLOGICAL PARAMETERS AFFECTING ISOLATED TUMOR CELL MORPHOLOGY IN NON SMALL CELL LUNG CANCER
    Funaki, Soichiro
    Sawabata, Noriyoshi
    Abulaiti, Abulimiti
    Nakagiri, Tomoyuki
    Shintani, Yasushi
    Kadota, Yoshiki
    Inoue, Masayoshi
    Minami, Masato
    Morii, Eiichi
    Aozasa, Katuyuki
    Okumura, Meinoshin
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S973 - S974
  • [49] Prognostic Significance of IgA plus B Cells in Non-Small Cell Lung Cancer
    Vanderputten, M.
    Aboubakar, F.
    Bouzin, C.
    Hoton, D.
    Pop, C. Stanciu
    Lecocq, M.
    Ambroise, J.
    Pilette, C.
    Ocak, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S569 - S569
  • [50] The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer
    Bian, Nan-Nan
    Shi, Xin-Yu
    Qi, Hong-Yu
    Hu, Xin
    Ge, Yang
    An, Guang-Yu
    Feng, Guo-Sheng
    MEDICINE, 2019, 98 (32)